FI833768A0 - Material och foerfaranden foer herpes simplex-virusvaccination - Google Patents

Material och foerfaranden foer herpes simplex-virusvaccination

Info

Publication number
FI833768A0
FI833768A0 FI833768A FI833768A FI833768A0 FI 833768 A0 FI833768 A0 FI 833768A0 FI 833768 A FI833768 A FI 833768A FI 833768 A FI833768 A FI 833768A FI 833768 A0 FI833768 A0 FI 833768A0
Authority
FI
Finland
Prior art keywords
virusvaccination
fares
herpes simplex
material och
och
Prior art date
Application number
FI833768A
Other languages
English (en)
Other versions
FI73885B (fi
FI833768A (fi
FI73885C (fi
Inventor
Gary H Cohen
Roselyn J Eisenberg
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26996451&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI833768(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University Patents Inc filed Critical University Patents Inc
Publication of FI833768A publication Critical patent/FI833768A/fi
Publication of FI833768A0 publication Critical patent/FI833768A0/fi
Priority to FI864102A priority Critical patent/FI83880C/fi
Publication of FI73885B publication Critical patent/FI73885B/fi
Application granted granted Critical
Publication of FI73885C publication Critical patent/FI73885C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/224—Herpes related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FI833768A 1982-02-18 1983-10-17 Foerfarande foer isolering av ett motstaondskraftfoermedlande preparat av herpes simplex -virus typ 1:s hoeljeglykoprotein gd-1 och herpes simplex -virus typ 2:s hoeljeglykoprotein gd-2 ur ett vaetskeprov. FI73885C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI864102A FI83880C (fi) 1982-02-18 1986-10-10 Foerfarande foer framstaellning av en polypeptid, som aer anvaendbar vid alstring av immunologiskt gensvar mot herpes simplex-infektioner.

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US35002182A 1982-02-18 1982-02-18
US35002182 1982-02-18
US46314183 1983-02-04
US06/463,141 US4762708A (en) 1982-02-18 1983-02-04 Materials and methods for herpes simplex virus vaccination
US8300182 1983-02-14
PCT/US1983/000182 WO1983002897A1 (en) 1982-02-18 1983-02-14 Materials and methods for herpes simplex virus vaccination

Publications (4)

Publication Number Publication Date
FI833768A FI833768A (fi) 1983-10-17
FI833768A0 true FI833768A0 (fi) 1983-10-17
FI73885B FI73885B (fi) 1987-08-31
FI73885C FI73885C (fi) 1987-12-10

Family

ID=26996451

Family Applications (2)

Application Number Title Priority Date Filing Date
FI833768A FI73885C (fi) 1982-02-18 1983-10-17 Foerfarande foer isolering av ett motstaondskraftfoermedlande preparat av herpes simplex -virus typ 1:s hoeljeglykoprotein gd-1 och herpes simplex -virus typ 2:s hoeljeglykoprotein gd-2 ur ett vaetskeprov.
FI864102A FI83880C (fi) 1982-02-18 1986-10-10 Foerfarande foer framstaellning av en polypeptid, som aer anvaendbar vid alstring av immunologiskt gensvar mot herpes simplex-infektioner.

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI864102A FI83880C (fi) 1982-02-18 1986-10-10 Foerfarande foer framstaellning av en polypeptid, som aer anvaendbar vid alstring av immunologiskt gensvar mot herpes simplex-infektioner.

Country Status (20)

Country Link
US (1) US4762708A (fi)
EP (1) EP0101506B1 (fi)
JP (3) JP2665332B2 (fi)
KR (1) KR910006889B1 (fi)
AR (1) AR231496A1 (fi)
AT (1) ATE54827T1 (fi)
AU (1) AU554710B2 (fi)
CA (1) CA1236774A (fi)
DE (1) DE3381761D1 (fi)
DK (1) DK172619B1 (fi)
ES (1) ES8406199A1 (fi)
FI (2) FI73885C (fi)
GR (1) GR77900B (fi)
HU (1) HU195734B (fi)
IE (1) IE56479B1 (fi)
IL (5) IL80895A (fi)
NO (2) NO162366B (fi)
NZ (1) NZ220771A (fi)
PH (1) PH25689A (fi)
WO (1) WO1983002897A1 (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540669A (en) * 1980-09-11 1985-09-10 Merck & Co., Inc. Herpes simplex type I subunit vaccine
US5149660A (en) * 1982-02-18 1992-09-22 University Patents, Inc. Diagnostic reagents relating to herpes simplex virus
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
JPS6051120A (ja) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニットワクチン
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
ATE72123T1 (de) * 1985-04-19 1992-02-15 Wistar Inst Impfstoff fuer die erzeugung einer gegen ein virus schuetzenden immunogenen t-zellen-antwort.
GB8605390D0 (en) * 1986-03-05 1986-04-09 Univ Birmingham Live herpes simplex vaccine
EP0471778A1 (en) * 1989-05-12 1992-02-26 Ciba Corning Diagnostics Corp. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US5654174A (en) * 1995-07-07 1997-08-05 Competitive Technologies, Inc. Herpes simplex virus glycoprotein D variants
AU2001286407A1 (en) * 2000-08-01 2002-03-04 University Of Pittsburgh Of The Commonwealth System Of Higher Education Antiviral compounds derived from the hsv gd protein and methods
US20030219448A1 (en) * 2002-05-24 2003-11-27 Cedars-Sinai Medical Center Peptide epitope-based vaccine for treating herpes simplex virus infections and related diseases
ATE494907T1 (de) 2002-07-18 2011-01-15 Univ Washington Pharmazeutische zusammensetzungen, die immunologisch aktive herpes simplex virus proteinfragmente enthalten
EP2289547B1 (en) * 2003-09-12 2015-12-16 Agenus Inc. Vaccine for treatment and prevention of herpes simplex virus infection
AU2007292905B2 (en) * 2006-09-08 2013-05-23 The Trustees Of The University Of Pennsyvania HSV-1 and HSV-2 vaccines and methods of use thereof
US8865185B2 (en) * 2006-09-08 2014-10-21 The Trustees Of The University Of Pennsylvania Methods of use for HSV-1 and HSV-2 vaccines
US8057804B2 (en) * 2006-12-28 2011-11-15 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
WO2008085486A1 (en) * 2006-12-28 2008-07-17 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US10478490B2 (en) * 2006-12-28 2019-11-19 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US20130028925A1 (en) * 2006-12-28 2013-01-31 Harvey Friedman Herpes simplex virus combined subunit vaccines and methods of use thereof
US9089537B2 (en) 2010-02-26 2015-07-28 The Trustees Of The University Of Pennslyvania Subunit vaccines for herpes viruses and methods of use
CA2832738A1 (en) * 2011-04-08 2012-10-11 Duke University Herpes simplex virus
PL2850431T3 (pl) 2012-05-16 2018-09-28 Immune Design Corp. Szczepionki przeciwko HSV-2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
YU44186B (en) * 1978-12-22 1990-04-30 Biogen Nv Process for obtaining recombinant dnk molecules

Also Published As

Publication number Publication date
GR77900B (fi) 1984-09-25
FI73885B (fi) 1987-08-31
NZ220771A (en) 1990-09-26
AU1339683A (en) 1983-09-08
DK479083D0 (da) 1983-10-17
IL80895A (en) 1990-02-09
JPH0797396A (ja) 1995-04-11
JPH0769924A (ja) 1995-03-14
EP0101506B1 (en) 1990-07-25
NO172745B (no) 1993-05-24
EP0101506A1 (en) 1984-02-29
NO842962L (no) 1983-10-17
JP2665332B2 (ja) 1997-10-22
JPS59500216A (ja) 1984-02-16
DK479083A (da) 1983-10-17
NO833773L (no) 1983-10-17
IL80896A0 (en) 1987-03-31
AR231496A1 (es) 1984-12-28
FI833768A (fi) 1983-10-17
IL67930A0 (en) 1983-06-15
FI83880B (fi) 1991-05-31
DK172619B1 (da) 1999-03-01
NO172745C (no) 1993-09-01
EP0101506A4 (en) 1984-07-06
IL67930A (en) 1990-02-09
ATE54827T1 (de) 1990-08-15
IL80896A (en) 1990-02-09
ES519875A0 (es) 1984-08-01
IL80895A0 (en) 1987-03-31
FI864102A (fi) 1986-10-10
AU554710B2 (en) 1986-08-28
NO162366B (no) 1989-09-11
PH25689A (en) 1991-09-04
JP2567202B2 (ja) 1996-12-25
KR840003420A (ko) 1984-09-08
FI83880C (fi) 1991-09-10
JP2669594B2 (ja) 1997-10-29
HU195734B (en) 1988-07-28
IE830332L (en) 1983-08-18
DE3381761D1 (de) 1990-08-30
IE56479B1 (en) 1991-08-14
KR910006889B1 (ko) 1991-09-10
CA1236774A (en) 1988-05-17
US4762708A (en) 1988-08-09
ES8406199A1 (es) 1984-08-01
FI864102A0 (fi) 1986-10-10
FI73885C (fi) 1987-12-10
WO1983002897A1 (en) 1983-09-01

Similar Documents

Publication Publication Date Title
FI833768A0 (fi) Material och foerfaranden foer herpes simplex-virusvaccination
FI824321A0 (fi) Oeverdrag foer en roekningsprodukt och foerfarande
FI824319L (fi) Oeverdrag foer en roekningsprodukt och foerfarande
FI824320L (fi) Oeverdrag foer en roekningsprodukt och foerfarande
FI831097A0 (fi) Kirurgiskt krampfaestningsinstrument och kassett foer detta
FI831591L (fi) Azolylmetyloxiraner deras framstaellningsfoerfarande och dessainnehaollande fungicider
FI830078L (fi) Askorbinsyraetrar och liknande foereningar
FI821571A0 (fi) Foerpackningsaemne och foerpackningsfoerfarande
FI832382A0 (fi) Fenylalfa-acyloxyacetamidderivat och deras terapeutiska anvaendning
FI831342L (fi) Verktygsanordning foer spaorstampning, -planing och sidoriktning
FI831085A0 (fi) Rakhyvel och rakaggregat foer rakhyvel
FI830846A0 (fi) Anslutningsorgan foer kabelledare och intagstraodskabel
FI831589L (fi) Trifunktionell ledningsfoerdelarenhet och uttag foer denna
FI830779L (fi) Eldretarderande sammansatta fibrer och foerfarande foer deras framstaellning
FI831771L (fi) Vaeggreglar och kopplingsdon foer dessa
FI830482L (fi) Cylindriskt skaerverktyg och haollaranordning foer detta
FI830336L (fi) Herbisida heterocyckliska foereningar och blandningar
FI832267A0 (fi) Isolationsmantelsegment och foerfarande foer framstaellning daerav
FI832069L (fi) Aminbenzamidderivat och deras framstaellning
FI821383A0 (fi) Foerfarande och anordning foer tandroentgenavbildning
FI65586B (fi) Saekerhetskoppling foer baotar motorslaedar och liknande
FI820384A (fi) Foerpackning och foerpackningsfoerfarande
FI822115A0 (fi) Rakhyvel och rakenhet daertill
FI822584A0 (fi) Bultlaos foer kontainer och liknande
FI822804L (fi) Stomme foer ventilgrupper foer uppvaermnings- och bruksvattensystem och liknande

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: UNIVERSITY PATENTS, INC.